Gibco™ Human Suspension Hepatocytes, Metabolism Qualified, Female, (4-8 x 10⁶ cells)

Human Suspension Hepatocytes, Metabolism Qualified, Female, (4-8 x 10⁶ cells)

These cryopreserved human female hepatocytes are suitable for use in suspension metabolism applications.

Cells per vial: 4–8 million

The commonly tested Phase I (P450) and Phase II (UGT, SULT) drug metabolizing enzymes were analyzed for metabolic activity in each lot. Metabolite formation was measured by standard biochemical assays using LC/MS/MS or HPLC.

Get the Results You Need with GIBCO Hepatocytes
High quality hepatocytes, with high viabilities, in vivo-like enzyme expression levels, and proper cell morphology increase the ability to draw in vitro⁄in vivo correlations and make sound decisions regarding a compound's fate. Experienced technicians and proprietary isolation techniques combined with stringent release specifications ensure you receive the highest quality cryopreserved hepatocytes.

Each lot is tested for:

Phase I and II enzyme activities

Proper morphology

Viabilities generally >75%

For research use only. Not intended for human or animal therapeutic or diagnostic use.

Related Links:

Learn more about our cryopreserved hepatocytes

Learn about our full line of hepatocytes ,

Note:
These products require shipment in LN₂ vapor dewars therefore additional fees may apply.

Content And Storage

Vials of cryopreserved hepatocytes should be stored in a cryostorage dewar or -135°C freezer.

Cell Type

Hepatocytes

Culture Type

Suspension Cell Culture

Form

Cryopreserved

Gender

Female

Species

Human

Donor Source

Single Donor

No. of Cells

4-8 x 10⁶

Product Line

Gibco™

Product Type

Hepatocytes

Quantity

1 vial

Tested For

Phase I and II Enzyme Activity, Proper Morphology, Viability Generally >75%

For Research Use Only. Not for use in diagnostic procedures.